Radiology Associates of Hartford is now providing patients with a groundbreaking, non-invasive diagnostic option for suspected coronary artery disease (CAD) through HeartFlow FFRCT analysis.
This advanced technology uses CT imaging and artificial intelligence to generate a personalized, 3D model of the heart. By combining anatomy with CT-derived fractional flow reserve (FFRCT), the HeartFlow analysis allows physicians to better evaluate blood flow and identify blockages or narrowing in the coronary arteries with greater accuracy.
Heart disease remains the leading cause of death in the United States, and CAD—the most common form—affects nearly half of all adults. CAD develops when the arteries supplying blood to the heart become narrowed or blocked, which may result in chest pain, heart attacks, or even death.
“By clearly showing us where and how the arteries are narrowed, the HeartFlow FFRCT analysis allows us to create a more precise treatment plan for each patient,” said Anthony Posteraro, III, M.D., Radiologist at Radiology Associates of Hartford. “This technology not only improves accuracy in diagnosing CAD but also helps us determine the most effective approach to care, while avoiding unnecessary invasive procedures.”
Traditional non-invasive tests for CAD often lack accuracy, which can lead to uncertainty in diagnosis and treatment. The HeartFlow analysis bridges this gap by offering physicians a clearer, more reliable view of the patient’s coronary health.
Benefits of HeartFlow FFRCT Analysis Include:
- A more accurate, non-invasive diagnosis of coronary artery disease
- Reduced need for unnecessary procedures, improving the patient experience
- Greater confidence in identifying which patients will truly benefit from intervention
“This is truly transformative technology,” added Dr. Posteraro. “It allows us to deliver more personalized, efficient, and effective care to our patients.”
Radiology Associates of Hartford is proud to bring this innovative tool to the community, giving patients and providers access to one of the most advanced diagnostic options available for heart disease today.
